Infarct-size limitation by preconditioning is enhanced by dipyridamole administered before but not after preconditioning: Evidence for the role of interstitial adenosine level during preconditioning as a primary determinant of cardioprotection

Journal of Cardiovascular Pharmacology

Volumn 31, Issue 1, 1998, Pages 1-9

  Suzuki, Katsuo ^a   Miura, Tetsuji ^a,b   Miki, Takayuki ^a   Tsuchida, Akihito ^a   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Adenosine Preconditioning Infarct size Dipyridamole

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; PROTEIN KINASE C; PURINE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DRUG EFFECT; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; HEMODYNAMIC PARAMETERS; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ADENOSINE; ANIMALS; DIPYRIDAMOLE; HEMODYNAMIC PROCESSES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; PURINES; RABBITS; VASODILATOR AGENTS;

EID: 0031964063     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199801000-00001     Document Type: Article

References (36)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36
2. Downey JM, Miura T. The role of adenosine in ischemic preconditioning. In: Hori M, Maruyama Y, Reneman RS, eds. Cardiac adaptation and failure. Tokyo: Springer-Verlag, 1994:147-66.
3. 1 receptor activation is abolished by protein kinase C inhibitors in the rabbit. Cardiovasc Rex 1995;29:682-8.
4. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994; 266: H1145-52.
5. Speechy-Dick ME, Mocanu MM, Yellon DM. Protein kinase C: its role in ischemic preconditioning in the rat. Circ Res 1994;75:586-90.
6. Miura T, Goto M, Miki T, Sakamoto J, Shimamoto K, Iimura O. Glibenclamide, a blocker of ATP-sensitive potassium channels, abolishes infarct size limitation by preconditioning in rabbits anesthetized with xylazine/pentobarbital but not with pentobarbital alone. J Cardiovasc Pharmacol 1995;25:531-8.
7. Yamasaki K, Tanaka M, Yokota R, Miyamac M, Sasayama S. Preconditioning with 15-min ischemia extends myocardial infarct size after subsequent 30-min ischemia in rabbits [Abstract]. J Mol Cell Cardiol 1994;26:CCXIV.
8. Van Winkle DM, Thornton J, Downey DM, Downey JM. The natural history of preconditioning: cardioprotection depends on duration of transient ischemia and time to subsequent ischemia. Coron Artery Dis 1991;2:613-9.
9. Wall TM, Sheehy R, Hartman JC. Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther 1994;270:681-9.
10. Goto M, Liu Y, Yang X-M, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995;77:611-21.
11. Thornton J, Thornton CS, Downey JM. Effect of adenosine receptor blockade: preventing protective preconditioning depends on time of initiation. Am J Physiol 1993;265:H504-8.
12. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 1994;75:576-85.
13. Van Wylen DGL. Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation 1994;89:2283-9.
14. Lasley RD, Konyn PJ, Hegge JO, Mentzer Jr RM. Effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size. Am J Physiol 1995;269:HI460-6.
15. Miura T, Suzuki K, Shimamoto K, Iimura O. Suppression of the degradation of adenine nucleotides during ischemia may not be a sufficient mechanism for infarct size limitation by preconditioning. Basic Res Cordiol 1996;91:425-32.
16. Yanagi K. Distortion free digital low pass filter for chromatography. In: Doyama M, Kihara J, Tanaka M, Yamamoto R. eds. Computer aided innovation of new materials II. Amsterdam: Elsevier Science B.V., 1993:939-40.
17. Nachlas NM, Schnitka TK. Macroscopic identification of early myocardial infarction by alterations in dehydrogenase activity. Am J Pathol 1963;42:379-405.
18. 1-adenosine receptors in the rabbit heart. Circulation 1991;84:350-6.
19. Miura T, Ogawa T, Iwamoto T, Shimamoto K, Iimura O. Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning. Circulation 1992;86:979-85.
20. Itoya M, Miura T, Sakamoto J, Urabe K, Iimura O. Nucleoside transport inhibitors enhance the infarct size-limiting effect of ischemic preconditioning. J Cardiovasc Pharmacol 1994;24:846-52.
21. Knabb RM, Gidday JM, Ely SW, Rubio R, Berne RM. Effects of dipyridamole on myocardial adenosine and active hyperemia. Am J Physiol 1984;247:H804-10.
22. Tietjan CS, Tribble CG, Gidday JM, et al. Interstitial adenosine in guinea pig hearts: an index obtained by epicardial disks. Am J Physiol 1990;259:III471-6.
23. Kitakaze M, Hori M, Takashima S, Sato H, Inoue M, Kamada T. Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs: implications for myocardial salvage. Circulation 1993;87:208-15.
24. Kroll K, Stepp DW. Adenosine kinetics in canine coronary circulation. Am J Physiol 1996;270:H1469-83.
25. Van Wylen DGL, Willis J, Sodhi J, Weiss RJ, Lasley RD, Mentzer RM Jr. Cardiac microdialysis to measure interstitial adenosine and coronary blood flow. Am J Physiol 1990;259:H1642-8.
26. Wikstrom G, Ronquist G, Waldenstrom A. Dynamics of myocardial metabolism in the preconditioned porcine heart studied using continuous microdialysis. Eur Heart J 1995;16:563-9.
27. Delyani JA, Van Wylen DGL. Endocardial and epicardial interstitial purines and lactate during graded ischemia. Am J Physiol 1994;266:H1019-26.
28. Reimer KA, Jennings RB. The "wavefront phenomenon" of myocardial ischemic death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979;40:633-44.
29. Jugdutt BI, Hutchins GM, Bulkley BH, Becker LC. Myocardial infarction in the conscious dog: three-dimensional mapping of infarct, collateral flow and region at risk. Circulation 1979;60: 1141-50.
30. Wang T, Mentzer RM Jr, Van Wylen DGL. Interstitial adenosine with dipyridamole: effect of adenosine receptor blockade and adenosine deaminase. Am J Physiol 1992;263:H552-8.
31. Borgers M, Thone F. Species differences in adenosine metabolic sites in the heart. Histochem J 1992;24:445-52.
32. Tucker AL, Linden J. Cloned receptors and cardiovascular responses to adenosine. Cardiovasc Res 1993;27:62-7.
33. Przyklenk K, Sussman MA, Simkhovich BZ, Kloner RA. Does ischemic preconditioning trigger translocation of protein kinase C in the canine heart? Circulation 1995;92:1546-57.
34. Mitchell MB, Meng X, Ao L, Brown JM. Harken AH, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 1995;76:73-81.
35. Prasad MR, Jones RM. Enhanced membrane protein kinase C activity in myocardial ischemia. Basic Res Cardiol 1992;87:19-26.
36. Vogt A, Barancik M, Weihrauch D, Arras M, Podzuweit T, Schaper W. Protein kinase C inhibitors reduce infarct size in pig hearts in vivo [Abstract]. Circulation 1994;90(suppl I):I-647.